HomeCompareSAVAW vs JEPQ

SAVAW vs JEPQ: Dividend Comparison 2026

SAVAW yields 6666.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAVAW wins by $1028095347812062.00M in total portfolio value
10 years
SAVAW
SAVAW
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full SAVAW calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — SAVAW vs JEPQ

📍 SAVAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAVAWJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAVAW + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAVAW pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAVAW
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, SAVAW beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAVAW + JEPQ for your $10,000?

SAVAW: 50%JEPQ: 50%
100% JEPQ50/50100% SAVAW
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAVAW buys
0
JEPQ buys
0
No recent congressional trades found for SAVAW or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAVAWJEPQ
Forward yield6666.67%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1028095347812062.00M$44.8K
Annual income after 10y$998,628,545,336,266,700,000.00$2,152.59
Total dividends collected$1026118102492338.88M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SAVAW vs JEPQ ($10,000, DRIP)

YearSAVAW PortfolioSAVAW Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$677,367$666,666.67$11,930$1,110.39+$665.4KSAVAW
2$42,928,313$42,203,530.63$14,133$1,224.34+$42.91MSAVAW
3$2,545,616,701$2,499,683,405.64$16,632$1,340.46+$2545.60MSAVAW
4$141,255,910,403$138,532,100,533.89$19,454$1,457.97+$141255.89MSAVAW
5$7,335,374,338,812$7,184,230,514,680.15$22,626$1,576.08+$7335374.32MSAVAW
6$356,516,885,536,661$348,668,034,994,132.70$26,175$1,694.09+$356516885.51MSAVAW
7$16,218,956,689,966,618$15,837,483,622,442,392.00$30,133$1,811.32+$16218956689.94MSAVAW
8$690,711,023,145,868,900$673,356,739,487,604,600.00$34,531$1,927.17+$690711023145.83MSAVAW
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$39,403$2,041.08+$27539067734387.94MSAVAW
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$44,787$2,152.59+$1028095347812062.00MSAVAW

SAVAW vs JEPQ: Complete Analysis 2026

SAVAWStock

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.

Full SAVAW Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this SAVAW vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAVAW vs SCHDSAVAW vs JEPISAVAW vs OSAVAW vs KOSAVAW vs MAINSAVAW vs XYLDSAVAW vs QYLDSAVAW vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.